Home

Peter Ordentlich, Chief Scientific Officer: Syndax Pharmaceuticals SNDX Sell · Filed 23/02/17

Trade details

Type
Insider sale
Amount
$450,339.52
Shares · price
17,428 sh · $25.84 a share
Held after
0 sh
Trade date
23/02/15
Filed
23/02/17
Days to filing
2 days

Sold 100.0% of holdings

Share of holding sold
100.0%

Syndax Pharmaceuticals trades, last 26 weeks

What else happened in Syndax Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 23/01/16~23/03/17

Peter Ordentlich's recent trades

  • Peter Ordentlich

    SellSyndax Pharmaceuticals

    $195.7K

    Filed 23/02/17

  • Peter Ordentlich

    SellSyndax Pharmaceuticals

    $1,962

    Filed 23/02/03